LUMOS PHARMA, INC.
DelistedCIK 1126234fmd_1NNQP97YVHHYAF9QE61Q8PSB9TManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2000 to Sep 30, 2024, 67 periods
Latest annual · FY2023
Millions- Total revenues
- 2
- Operating income
- (37)
- Net income
- (34)
Latest quarter · Q3 FY2024
Millions- Total revenues
- 1
- Operating income
- (8)
- Net income
- (7)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2020 to FY2023
- +130.3%
- Revenue, 5 yearsFY2018 to FY2023
- -30.3%
- Net income, 5 yearsFY2018 to FY2023
- n/m
LUMOS PHARMA, INC. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2023 | FY2022 | Change | Source |
|---|---|---|---|---|
| Revenue | $2.1 million | $1.5 million | +34.7% | 10-K 2024-03-07 · proof |
| Operating income | -$36.6 million | -$32 million | 10-K 2024-03-07 · proof | |
| Net income | -$34 million | -$31.1 million | 10-K 2024-03-07 · proof | |
| Cash from operating activities | -$31.1 million | -$26.6 million | 10-K 2024-03-07 · proof | |
| Total assets | $40.6 million | $72.3 million | -43.8% | 10-K 2024-03-07 · proof |
| Total liabilities | $13.3 million | $12.7 million | +4.9% | 10-K 2024-03-07 · proof |
| Cash and cash equivalents | $35.1 million | $56 million | -37.4% | 10-K 2024-03-07 · proof |
- What was LUMOS PHARMA, INC.'s revenue in fiscal 2023?
- LUMOS PHARMA, INC. reported revenue of $2.1 million for fiscal 2023 (the year ended Dec 31, 2023), against $1.5 million the year before (+34.7%). Source: the 10-K filed with the SEC on Mar 7, 2024. SEC
- What was LUMOS PHARMA, INC.'s operating income in fiscal 2023?
- LUMOS PHARMA, INC. reported operating income of -$36.6 million for fiscal 2023 (the year ended Dec 31, 2023), against -$32 million the year before. Source: the 10-K filed with the SEC on Mar 7, 2024. SEC
- What was LUMOS PHARMA, INC.'s net income in fiscal 2023?
- LUMOS PHARMA, INC. reported net income of -$34 million for fiscal 2023 (the year ended Dec 31, 2023), against -$31.1 million the year before. Source: the 10-K filed with the SEC on Mar 7, 2024. SEC
- What was LUMOS PHARMA, INC.'s cash from operating activities in fiscal 2023?
- LUMOS PHARMA, INC. reported cash from operating activities of -$31.1 million for fiscal 2023 (the year ended Dec 31, 2023), against -$26.6 million the year before. Source: the 10-K filed with the SEC on Mar 7, 2024. SEC
- What are LUMOS PHARMA, INC.'s total assets?
- As of Dec 31, 2023, LUMOS PHARMA, INC. reported total assets of $40.6 million, against $72.3 million a year earlier (-43.8%). Source: the 10-K filed with the SEC on Mar 7, 2024. SEC
- What are LUMOS PHARMA, INC.'s total liabilities?
- As of Dec 31, 2023, LUMOS PHARMA, INC. reported total liabilities of $13.3 million, against $12.7 million a year earlier (+4.9%). Source: the 10-K filed with the SEC on Mar 7, 2024. SEC
- What are LUMOS PHARMA, INC.'s cash and cash equivalents?
- As of Dec 31, 2023, LUMOS PHARMA, INC. reported cash and cash equivalents of $35.1 million, against $56 million a year earlier (-37.4%). Source: the 10-K filed with the SEC on Mar 7, 2024. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1126234&period_type=annual&limit=5"Information only, not investment advice.